ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

AACR Grant Programs. NIH RFA Available.

June 29, 2001

In Brief: Flood At Ohio’s Arthur James Cancer Hospital Sets Back Opening; Biometry Article Honored

January 19, 1990